Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 9 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of FUT7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 111.21 | 574 / 578 | 44% | 1.05 | 511 / 1155 |
thymus | 77% | 27.54 | 506 / 653 | 53% | 1.90 | 320 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.57 | 29 / 29 |
spleen | 100% | 695.19 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 3893.62 | 900 / 929 | 0% | 0 | 0 / 0 |
intestine | 53% | 18.80 | 510 / 966 | 36% | 0.92 | 189 / 527 |
skin | 46% | 12.36 | 838 / 1809 | 40% | 1.28 | 188 / 472 |
stomach | 60% | 18.43 | 215 / 359 | 23% | 0.60 | 66 / 286 |
brain | 75% | 44.05 | 1969 / 2642 | 6% | 0.10 | 41 / 705 |
uterus | 34% | 7.73 | 58 / 170 | 46% | 1.47 | 211 / 459 |
tonsil | 0% | 0 | 0 / 0 | 80% | 4.73 | 36 / 45 |
breast | 42% | 8.63 | 195 / 459 | 35% | 1.00 | 386 / 1118 |
bladder | 43% | 9.95 | 9 / 21 | 31% | 0.82 | 157 / 504 |
adipose | 72% | 27.89 | 862 / 1204 | 0% | 0 | 0 / 0 |
prostate | 55% | 12.51 | 135 / 245 | 7% | 0.11 | 33 / 502 |
adrenal gland | 45% | 9.66 | 115 / 258 | 17% | 0.68 | 39 / 230 |
esophagus | 51% | 16.23 | 734 / 1445 | 5% | 0.10 | 9 / 183 |
kidney | 37% | 11.83 | 33 / 89 | 17% | 0.29 | 155 / 901 |
liver | 38% | 9.12 | 86 / 226 | 12% | 0.35 | 47 / 406 |
pancreas | 11% | 2.18 | 35 / 328 | 35% | 0.82 | 63 / 178 |
heart | 43% | 9.44 | 371 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 38% | 10.42 | 501 / 1335 | 0% | 0 | 0 / 0 |
ovary | 12% | 2.58 | 21 / 180 | 11% | 0.16 | 46 / 430 |
muscle | 3% | 0.58 | 28 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.06 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002522 | Biological process | leukocyte migration involved in immune response |
GO_0006954 | Biological process | inflammatory response |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_1903037 | Biological process | regulation of leukocyte cell-cell adhesion |
GO_0022407 | Biological process | regulation of cell-cell adhesion |
GO_0036065 | Biological process | fucosylation |
GO_0097022 | Biological process | lymphocyte migration into lymph node |
GO_0002523 | Biological process | leukocyte migration involved in inflammatory response |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0042355 | Biological process | L-fucose catabolic process |
GO_1903236 | Biological process | regulation of leukocyte tethering or rolling |
GO_1903238 | Biological process | positive regulation of leukocyte tethering or rolling |
GO_2000389 | Biological process | regulation of neutrophil extravasation |
GO_1902624 | Biological process | positive regulation of neutrophil migration |
GO_0001807 | Biological process | regulation of type IV hypersensitivity |
GO_0002361 | Biological process | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO_1904996 | Biological process | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO_0072678 | Biological process | T cell migration |
GO_0046626 | Biological process | regulation of insulin receptor signaling pathway |
GO_0022409 | Biological process | positive regulation of cell-cell adhesion |
GO_0007566 | Biological process | embryo implantation |
GO_0060353 | Biological process | regulation of cell adhesion molecule production |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0008417 | Molecular function | fucosyltransferase activity |
GO_0017083 | Molecular function | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO_0046920 | Molecular function | alpha-(1->3)-fucosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FUT7 |
Protein name | Alpha-(1,3)-fucosyltransferase 7 (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase) |
Synonyms | |
Description | FUNCTION: Catalyzes the transfer of L-fucose, from a guanosine diphosphate-beta-L-fucose, to the N-acetyl glucosamine (GlcNAc) of a distal alpha2,3 sialylated lactosamine unit of a glycoprotein or a glycolipid-linked sialopolylactosamines chain through an alpha-1,3 glycosidic linkage and participates in the final fucosylation step in the biosynthesis of the sialyl Lewis X (sLe(x)), a carbohydrate involved in cell and matrix adhesion during leukocyte trafficking and fertilization . In vitro, also synthesizes sialyl-dimeric-Lex structures, from VIM-2 structures and both di-fucosylated and trifucosylated structures from mono-fucosylated precursors . However does not catalyze alpha 1-3 fucosylation when an internal alpha 1-3 fucosylation is present in polylactosamine chain and the fucosylation rate of the internal GlcNAc residues is reduced once fucose has been added to the distal GlcNAc . Also catalyzes the transfer of a fucose from GDP-beta-fucose to the 6-sulfated a(2,3)sialylated substrate to produce 6-sulfo sLex mediating significant L-selectin-dependent cell adhesion . Through sialyl-Lewis(x) biosynthesis, can control SELE- and SELP-mediated cell adhesion with leukocytes and allows leukocytes tethering and rolling along the endothelial tissue thereby enabling the leukocytes to accumulate at a site of inflammation . May enhance embryo implantation through sialyl Lewis X (sLeX)-mediated adhesion of embryo cells to endometrium . May affect insulin signaling by up-regulating the phosphorylation and expression of some signaling molecules involved in the insulin-signaling pathway through SLe(x) which is present on the glycans of the INSRR alpha subunit . . |
Accessions | Q11130 ENST00000314412.7 |